The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -32.76%.However, over the last six months, we can see a stronger performance of -34.18%. Over the last 30 days, the price of TECH has leaped by -20.45%. And in the last five days, it has fallen by -1.67%.
Bio-Techne Corp experienced a rather shaky stock market performance. The highest value in the past year was recorded at $85.57 on 05/15/24 and the lowest value was $46.44 on 04/09/25.
52-week price history of TECH Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Bio-Techne Corp’s current trading price is -43.40% away from its 52-week high, while its distance from the 52-week low is 4.30%. The stock’s price range during this period has varied between$46.44 and $85.57. The Bio-Techne Corp’s shares, which operate in the Healthcare, saw a trading volume of around 0.87 million for the day, a figure considerably lower than their average daily volume of 1.88 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Bio-Techne Corp (TECH) has experienced a quarterly decline of -36.35% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 7.66B and boasts a workforce of 3100 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 67.51, with a change in price of -20.30. Similarly, Bio-Techne Corp recorded 1,456,995 in trading volume during the last 100 days, posting a change of -29.54%.
TECH’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for TECH stands at 0.19. Similarly, the long-term debt-to-equity ratio is also 0.18.
TECH Stock Stochastic Average
Bio-Techne Corp’s raw stochastic average for the past 50 days is presently 6.47%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 12.60%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 21.02% and 26.64%, respectively.
